CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 94 filers reported holding CUE BIOPHARMA INC in Q3 2020. The put-call ratio across all filers is 0.71 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $69,384 | -64.2% | 14,218 | -17.1% | 0.00% | – |
| Q4 2021 | $194,000 | -24.5% | 17,147 | -2.8% | 0.00% | – |
| Q3 2021 | $257,000 | +18.4% | 17,646 | -5.4% | 0.00% | – |
| Q2 2021 | $217,000 | -6.9% | 18,661 | -2.5% | 0.00% | – |
| Q1 2021 | $233,000 | -2.9% | 19,131 | -0.3% | 0.00% | – |
| Q4 2020 | $240,000 | -4.0% | 19,195 | +15.5% | 0.00% | – |
| Q3 2020 | $250,000 | -35.6% | 16,626 | 0.0% | 0.00% | – |
| Q2 2020 | $388,000 | +103.1% | 16,626 | +23.4% | 0.00% | – |
| Q1 2020 | $191,000 | -10.7% | 13,476 | -0.3% | 0.00% | – |
| Q4 2019 | $214,000 | +65.9% | 13,511 | -7.1% | 0.00% | – |
| Q3 2019 | $129,000 | +8.4% | 14,549 | +9.5% | 0.00% | – |
| Q2 2019 | $119,000 | -33.5% | 13,287 | -12.3% | 0.00% | – |
| Q2 2018 | $179,000 | +67.3% | 15,154 | +97.6% | 0.00% | – |
| Q1 2018 | $107,000 | – | 7,669 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Corriente Advisors, LLC | 1,915,219 | $23,959,000 | 5.70% |
| Prosight Management, LP | 906,569 | $11,341,000 | 5.24% |
| P.A.W. CAPITAL CORP | 140,000 | $1,751,000 | 1.54% |
| Voss Capital, LLC | 220,714 | $2,761,000 | 1.39% |
| Robertson Stephens Wealth Management, LLC | 484,000 | $6,054,000 | 1.26% |
| Slate Path Capital LP | 1,483,619 | $18,560,000 | 1.00% |
| Nantahala Capital Management | 2,506,772 | $31,360,000 | 0.97% |
| PRECEPT MANAGEMENT LLC | 150,000 | $1,877,000 | 0.76% |
| SANDERS MORRIS HARRIS LLC | 193,591 | $2,449,000 | 0.56% |
| Rock Creek Group, LP | 100,014 | $1,251,000 | 0.51% |